DaVita Inc.

DVA Healthcare Medical Care Facilities

DaVita Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.6 billion, up 6.46% from fiscal 2024. In the quarter to June 2026, revenue grew 5.17%, EPS grew 56.5%, free cash flow grew 49.4% and total debt rose 4.40%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.

187.31 1.85 −0.98%
Market cap
$12.1B
P/E
15.0×
Fwd P/E
13.1×
Dividend yield
—
F-score
6/9
Altman Z
1.49
Beneish M
−2.59
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
17.83 13.97 11.23 13.37

+8 more quarters

P/S ratio
1.03 0.75 0.62 0.72
P/FCF ratio
8.01 6.12 5.56 6.36
P/Operating CF
29.41 32.28 15.60 11.38
P/B ratio
0.00 0.00 0.00 0.00
EV/Sales
1.75 1.47 1.33 1.43
EV/EBITDA
8.62 7.25 6.57 6.93
EV/FCF
13.59 12.00 11.94 12.65
Current Ratio
1.47 1.42 1.29 1.36
Net Debt/EBITDA
13.45 15.10 12.96 13.87
Debt/Equity
(22.44) (22.49) (28.02) (33.86)
Earnings Yield
5.61% 7.16% 8.91% 7.48%
Free Cash Flow Yield
12.48% 16.35% 18.00% 15.72%
Free Cash Flow per Share
4.95 3.30 5.35 9.51
Book value per Share
(7.44) (7.07) (5.03) (4.22)
Free Cash Flow
320.92 222.53 397.13 685.38
EV/EBIT
11.50 9.74 8.87 9.30
Other line items

Show all line items

Columns are period end dates